The Centers for Disease Control and Prevention's vaccine advisory committee wrapped up the first day of its meeting since ...

The panel, created more than 60 years ago, helps the CDC determine who should be vaccinated against a long list of diseases, ...

Among the 288 RSV cases with a known subtype, 73% were RSV B. Overall, the individuals had a median age of 72, a median Charlson Comorbidity Index score of 5, and 24.2% of them were immunocompromised.

The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to ...

In 2023, the FDA approved nirsevimab, which the CDC recommends for infants aged younger than 8 months who are born during or entering their first RSV season and are not otherwise protected because ...

With the U.S. FDA’s approval of Enflonsia (clesrovimab) to prevent respiratory syncytial virus (RSV) infection lower respiratory tract disease in newborns and infants, Merck & Co. Inc. steps into ...

The Centers for Disease Control and Prevention (CDC) advises looking for other symptoms associated with the NB.1.8.1 variant. Sat, 21 Jun 2025 08:30:18 GMT (1750494618649) Story Infinite Scroll ...

Symptoms for measles can be more than just a red and bumpy rash. People can also experience a high fever, cough, runny nose and red, watery eyes, according to the CDC.

The CDC reported the mistake involving two vaccines used to treat RSV. The vaccines were approved for distribution in May, but not for infants and pregnant women.

Currently, the most prevalent COVID-19 variant in the US is the LP.8.1, which made up 70 percent of reported cases between April 26 and May 10, according to the CDC website.